Outer Membrane Protein I of Pseudomonas aeruginosa Is a Target of Cationic Antimicrobial Peptide/Protein |
| |
Authors: | Yu-Min Lin Shih-Jung Wu Ting-Wei Chang Chiu-Feng Wang Ching-Shu Suen Ming-Jing Hwang Margaret Dah-Tsyr Chang Yuan-Tsong Chen You-Di Liao |
| |
Affiliation: | From the ‡Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, ;the §Department of Life Science, National Tsing-Hua University, Hsin-Chu 300, Taiwan, ;the ¶Institute of Microbiology, College of Medicine, National Taiwan University, Taipei 106, Taiwan, and ;the ‖Institute of Pharmacology, National Yang-Ming University, Taipei 112, Taiwan |
| |
Abstract: | Cationic antimicrobial peptides/proteins (AMPs) are important components of the host innate defense mechanisms against invading microorganisms. Here we demonstrate that OprI (outer membrane protein I) of Pseudomonas aeruginosa is responsible for its susceptibility to human ribonuclease 7 (hRNase 7) and α-helical cationic AMPs, instead of surface lipopolysaccharide, which is the initial binding site of cationic AMPs. The antimicrobial activities of hRNase 7 and α-helical cationic AMPs against P. aeruginosa were inhibited by the addition of exogenous OprI or anti-OprI antibody. On modification and internalization of OprI by hRNase 7 into cytosol, the bacterial membrane became permeable to metabolites. The lipoprotein was predicted to consist of an extended loop at the N terminus for hRNase 7/lipopolysaccharide binding, a trimeric α-helix, and a lysine residue at the C terminus for cell wall anchoring. Our findings highlight a novel mechanism of antimicrobial activity and document a previously unexplored target of α-helical cationic AMPs, which may be used for screening drugs to treat antibiotic-resistant bacterial infection. |
| |
Keywords: | Antimicrobial Peptides Protein/Protein-Protein Interactions Lipopolysaccharide (LPS) Membrane Proteins Protein Purification Pseudomonas aeruginosa SMAP-29 Ribonuclease 7 Target Protein |
|
|